Aegerion Pharmaceuticals, Inc. Announces Presentation At The 32nd Annual J.P. Morgan Healthcare Conference
Published: Jan 07, 2014
CAMBRIDGE, Mass., Jan. 7, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco. Marc Beer, CEO of Aegerion, is scheduled to present on Monday, January 13, 2014 at 2:30pm PT (5:30pm ET).
Help employers find you! Check out all the jobs and post your resume.